Physician profile
Lauree Jones
NPI 1275771198
$1,088.67
in general payments reported to CMS, 2019-2025
13 companies · $65.51 in 2025
The $65.51 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $62.60 · 2022: $49.52 · 2023: $223 · 2024: $478 · 2025: $65.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $441.20 | 2023-2024 | Qelbree, Qelbree |
| Corium, LLC | $208.69 | 2022-2024 | Azstarys |
| Pfizer INC. | $90.45 | 2019-2022 | |
| Tris Pharma INC | $64.30 | 2023-2025 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $54.25 | 2019-2023 | Bexsero |
| Merck Sharp & Dohme LLC | $44.49 | 2019-2025 | Vaxneuvance, Gardasil 9 |
| Sobi, INC | $41.96 | 2019 | |
| Genentech USA, INC. | $39.69 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.45 | 2019-2020 | |
| Sanofi Pasteur INC. | $20.09 | 2020 | |
| Ironshore Pharmaceuticals INC. | $18.98 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.48 | 2024 | Relexxii |
| Avion Pharmaceuticals | $13.64 | 2023 | Methylphenidate Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauree Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.